The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.300
+0.040 (1.23%)
At close: Sep 5, 2025, 4:00 PM
3.450
+0.150 (4.55%)
After-hours: Sep 5, 2025, 7:22 PM EDT

The Oncology Institute Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for The Oncology Institute stock has a target of 6.00, which predicts a 81.82% increase from the current stock price of 3.3.

Price Target: $6.00 (+81.82%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$6.00$6.00$6.00$6.00
Change+81.82%+81.82%+81.82%+81.82%
* Price targets were last updated on Jul 16, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for The Oncology Institute is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222211
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total222211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B. Riley Securities
B. Riley Securities
Strong Buy
Initiates
$6
Strong BuyInitiates$6+81.82%Jul 16, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$2.5
Strong BuyInitiates$2.5-24.24%Feb 26, 2024
Guggenheim
Guggenheim
Strong Buy
Maintains
$3$2
Strong BuyMaintains$3$2-39.39%Jun 16, 2023
Guggenheim
Guggenheim
Hold
Maintains
$6$3
HoldMaintains$6$3-9.09%Mar 20, 2023
Guggenheim
Guggenheim
Strong Buy
Maintains
$7$6
Strong BuyMaintains$7$6+81.82%Nov 11, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
479.80M
from 393.41M
Increased by 21.96%
Revenue Next Year
577.37M
from 479.80M
Increased by 20.34%
EPS This Year
-0.61
from -0.71
EPS Next Year
-0.28
from -0.61
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
187.52M203.00M252.48M324.24M393.41M479.80M577.37M
Revenue Growth
20.66%8.26%24.37%28.42%21.33%21.96%20.34%
EPS
-0.24-0.16-0.21-0.92-0.71-0.61-0.28
EPS Growth
-------
Forward PE
-------
No. Analysts
-----32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
High499.1M611.5M
Avg479.8M577.4M
Low465.3M549.7M

Revenue Growth

Revenue Growth20252026
High
26.9%
27.5%
Avg
22.0%
20.3%
Low
18.3%
14.6%

EPS Forecast

EPS20252026
High-0.63-0.29
Avg-0.61-0.28
Low-0.59-0.27

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.